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Abstract
Introduction: Laparoscopic adrenalectomy (LA) has become the standardized treatment of benign adrenal lesions over the last two deca-
des, making the indications to open adrenalectomy (OA) limited. The purpose of this study was to show the thirty years of experience in
open (OA) and laparoscopic adrenalectomy (LA) gained in one medical centre as well as to compare the results of OA and LA performed
for benign adrenal lesions.
Material and methods: Three hundred patients underwent 127 open and 173 laparoscopic adrenalectomies between 1979 and 2009 at
M. Curie Hospital in Szczecin, Poland. Analyzed factors included patients demographic data, ASA score, indication for surgery, tumour size
and side, characteristics of the removed tumours, intraoperative and postoperative outcome of LA and OA, postoperative pain sensation,
intraoperative and postoperative complications, and conversion rate from LA to OA. Tumours with diameter exceeding 8 cm were excluded.
Results: There were no significant differences regarding the analyzed preoperative data in both groups of patients. The mean operative
time was longer in the LA group (137 v. 82 min., p < 0.0001) and the blood loss was lower in LA group (110 v. 254 mL, p < 0.0001). The mean
time until resumption of normal diet was shorter after LA (22 v. 44 h), as was the mean time until ambulation (17 v. 36 h), mean length of
the hospital stay (4.6 v. 6.8 days), and mean time until return to normal activities (14 v. 23 days, p < 0.0001 for each difference). The
analgesic requirement on the first and the second day postoperatively was lower in the LA group (p < 0.0001). The incidence of intraope-
rative and postoperative complications did not differ significantly between both analyzed groups. The rate of the conversion from LA to
OA was 16%. The histopathological diagnosis was adenoma of the adrenal gland in the majority of cases.
Conclusions: This study shows that LA is a safe, effective, and well-tolerated procedure. It may be recommended as a “gold standard”
surgery in a case of benign functioning or non-functioning adrenal tumours with diameter less than 8 cm.
(Pol J Endocrinol 2010; 61 (1): 94–101)
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Streszczenie
Wstęp: Adrenalektomia laparoskopowa (LA, laparoscopic adrenaloctomy) stała się w dwóch ostatnich dekadach standardowym postępowa-
niem w leczeniu operacyjnym łagodnych guzów nadnerczy, zawężając jednocześnie wskazania do adrenalektomii otwartej (OA, open
adrenaloctomy). Celem tego badania było przedstawienie 30-letniego doświadczenia w adrenalektomii otwartej i laparoskopowej, zebrane-
go w jednym ośrodku medycznym, jak również porównanie wyników OA i LA wykonanych z powodu łagodnych guzów nadnerczy.
Materiał i metody: Materiał stanowiło 300 pacjentów, u których przeprowadzono 127 otwartych i 173 laparoskopowych adrenalektomii
w latach 1979–2009 w Szpitalu im. M. Skłodowskiej-Curie w Szczecinie. Analizowanymi czynnikami były: dane demograficzne pacjentów,
wynik skali ASA, wskazanie do operacji, rozmiar guza i jego umiejscowienie, charakterystyka usuniętej zmiany, śródoperacyjne i poope-
racyjne wyniki LA i OA, pooperacyjne dolegliwości bólowe, śródoperacyjne i pooperacyjne powikłania, jak również wskaźnik konwersji
z LA do OA. Z analizy wykluczono guzy o średnicy przekraczającej 8 cm.
Wyniki: Nie stwierdzono istotnych różnic dotyczących analizowanych danych przedoperacyjnych w obu grupach pacjentów. Średni
czas operacji był dłuższy w grupie LA (137 v. 82 min, p < 0,0001), a utrata krwi była mniejsza w grupie LA (110 v. 254 ml, p < 0,0001). Średni
czas konieczny do wznowienia normalnej diety był krótszy po LA (22 v. 44 h), dotyczyło to również średniego czasu uruchomienia
chorych (17 v. 36 h), średniego czasu hospitalizacji (4,6 v. 6,8 dni), i średniego czasu powrotu do normalnej aktywności (14 v. 23 dni,
p < 0,0001 dla każdej zmiennej). Potrzeba stosowania środków przeciwbólowych w pierwszym i drugim dniu po operacji była mniejsza
w grupie LA (p < 0,0001). Częstość występowania powikłań śródoperacyjnych i pooperacyjnych nie różniła się istotnie pomiędzy obiema
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analizowanymi grupami. Wskaźnik konwersji z LA do OA wynosił 16%. W większości przypadków rozpoznaniem histopatologicznym
był gruczolak nadnercza.
Wnioski: Przeprowadzona analiza pokazuje, że LA jest bezpiecznym, efektywnym i dobrze tolerowanym przez chorych zabiegiem.
Adrenalektomia laparoskopowa może być rekomendowana jako „złoty standard” w chirurgii czynnych i nieczynnych hormonalnie łagod-
nych guzów nadnerczy o średnicy mniejszej niż 8 cm. (Endokrynol Pol 2010; 61 (1): 94–101)
Słowa kluczowe: guz nadnerczy, adrenalektomia laparoskopowa, adrenalektomia otwarta
Introduction
Open adrenalectomy (OA) had been considered the tre-
atment of choice for adrenal tumours for almost 80 years.
Regardless of the method of traditional adrenal surgery,
it requires a relatively large incision because the adrenal
glands are located deeply in the retroperitoneal space.
Since Go [1] performed the first laparoscopic adre-
nalectomy (LA) in January 1992, many studies have re-
ported morbidity of the procedure to be lower compa-
red to open surgery [2–6]. The adrenal glands appear
to be particularly suitable for laparoscopic excision as
most adrenal tumours are small and pathologically be-
nign. The benefits of laparoscopic adrenalectomy can
include reduced blood loss, lower requirements for anal-
gesia, shorter hospital stay, and quicker recovery. In
view of this, it was suggested that minimal invasive
adrenalectomy might lead to a better clinical outcome,
as compared to the open surgery. However, there are
not many single-centre studies in recent literature pro-
viding comprehensive analysis of large groups of pa-
tients undergoing OA and LA [6–11].
The aim of the study was to show the experience in
traditional and laparoscopic adrenalectomy gained in
one surgical centre during the last thirty years, inclu-
ding an outcome comparison obtained for OA and LA
performed for benign adrenal lesions.
Material and methods
Between 1979 and 2009, 300 patients (222 females), mean
age 52 (range 18–80 years) underwent OA (n = 127) and
LA (n = 173) in the Department of General and Trans-
plantation Surgery of M. Curie Hospital in Szczecin,
Poland. The first OA procedure was done in our de-
partment in 1979, and the first LA was performed in
1995. The majority of the patients with adrenal tumour
were diagnosed in the Department of Endocrinology,
Metabolic, and Internal Diseases, Pomeranian Medical
University in Szczecin, Poland. Their health status was
classified preoperatively according to the American
Association of Anaesthesiology (ASA) score. The stan-
dard endocrinological evaluation included the serum
level of 17-hydroxyprogesterone, testosterone, andro-
stendione, DHEA-S, aldosterone, ARO, ACTH, cortisol,
short test with 1 mg of dexamethasone, and the level of
metanephrines in the urine. The overall indications for
surgery were non-functioning adrenal tumours (n = 183),
pheochromocytoma (n = 36), Conn syndrome (n = 39),
Cushing syndrome (n = 39), and congenital adrenal
hypertrophy (CAH) (n = 3). The mean diameter of the
lesions diagnosed by CT was 4.2 cm (range 1.3–17 cm),
and the tumours were found on the left side in 116 ca-
ses and on right side in 164 cases while bilateral lesions
were present in 20 cases. The malignant adrenal tumo-
urs were suspected in 12 cases preoperatively.
Open adrenaloctomy was done employing a trans-
peritoneal (n = 61) as well as a lateral (n = 45) and po-
sterior (n = 21) approach. Although LA was planned to
be performed using lateral retroperitoneal (n = 131) and
transperitoneal (n = 42) access, it was converted to OA
in 28 cases.
We aimed to compare the outcome of OA and LA
performed for adrenal tumours in our centre. In order
to achieve comparable groups, patients with suspected
malignant adrenal tumours or lesions bigger than 8 cm
(n = 24) that were not considered for LA in our depart-
ment were excluded. The patients in whom conversion
from LA to OA was required were also excluded from
the comparison; however, the influence of the conver-
sion on the outcome of the operation and the postope-
rative course was also studied.
The following data of open (n = 78) and laparosco-
pic adrenalectomy (n = 140) as well as the conversion
from laparoscopic to open procedure were recorded and
analyzed: time of procedure, blood loss, time till re-
sumption of normal diet, time till full ambulation, in-
traoperative and postoperative complications, hospital
stay, and return to normal activity. The postoperative
pain sensation was evaluated based on the patient’s
need for analgesic administration during the first and
the second day after surgery using the five grade scale
as follows: 0 — no analgesics; I — sporadic oral intake
of 100 mg of ketoprofen ; II — one oral dose of 100 mg
of ketoprofen every 8 hours; III — parenteral admini-
stration of 100 mg of ketoprofen; IV — parenteral ad-
ministration of narcotic analgesics. Hospital stay was
calculated since the day of surgery. The patients were
asked about their return to normal activity during the
check-up visit in the outpatient department or by telepho-
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ne questionnaire. Each patient was questioned regarding
full return to home, work, social, or sport activities.
The data were analyzed with Mann-Whitney test
for quantitative variables and Chi-square or Fisher exact
test for qualitative variables. The calculations were per-
formed with Statistica 7.1 software.
Results
Classification of the physical status of the patients ac-
cording to the ASA score for the LA versus the OA gro-
up is presented in Figure 1. It shows the better preope-
rative health condition of patients undergoing OA.
The mean age in the LA group (range 18–79 years)
was significantly higher compared to the OA group
(range 18–71 years), while the ratio of male to female
sex was similar in both groups (Table I).
The mean size of adrenal tumour assessed by com-
puted tomography was significantly higher in patients
undergoing OA whereas the other preoperative varia-
bles were comparable (Table II).
The comparison of intraoperative and postoperati-
ve endpoints of laparoscopic and open adrenalectomy
is shown in Table III. The differences were statistically
significant in all evaluated parameters. Mean duration
of LA (range 50–370 min) was almost two times longer
than OA (range 35–190 min). However, the average
duration of the first 20 laparoscopic procedures was
180 minutes while the last 20 operations were done in
a mean time of 90 minutes. The above differences were
not observed in the OA Group. The mean blood loss
was approximately 150 ml less for LA (range 0–500 ml)
compared to OA (range 30–1800 ml). The average blo-
od loss observed in the first 20 and the last 20 LA was
185 and 108 ml, whereas it was 225 ml and 202 ml in the
case of the first 20 and the last 20 OA, respectively.
The patients from the LA group were able to resu-
me normal diet after a mean time of 1 day from surgery
Table I. The demographic data of the patients
Tabela I. Dane demograficzne pacjentów
Laparoscopic Open p value
(n = 140) (n = 78)
Age (years)
Mean ± SD 54.5 ± 11.9 50.4 ± 11.8 p = 0.042
Sex
Female 106 (75.7%) 58 (74.4%) p = 0.88
Male 34 (24.3%) 20 (25.6%)
Table II. Tumour characteristics and indications for surgery
Tabela II. Cechy guza i wskazania do zabiegu
Laparoscopic Open p value
Side n = 140 n = 78
Right 73 (52.2%) 46 (59.0%)
Left 59 (42.1%) 28 (35.9%) 0.62
Bilateral 8 (5.7%) 4 (5.1%)
Tumour size (cm)
Mean ± SD 3.7 ± 1.3 4.5 ± 1.7  < 0.0001
Indication n = 140 n = 78
Incidentaloma 89 (63.6%) 43 (55.1%)
Conn syndrome 22 (15.7%) 12 (15.4%)
Cushing syndrome 16 (11.4%) 10 (12.8%) 0.16
Pheochromocytoma 10 (7.2%) 13 (16.7%)
Cong. adrenal
hypertrophy 3 (2.1%) 0 (0%)
Table III. Intraoperative and postoperative outcome of LA
and OA
Tabela III. Śródoperacyjne i pooperacyjne wyniki LA i OA
Laparoscopic Open p value
Mean ± SD Mean ± SD
(n = 140) (n = 78)
Duration of surgery 136.6±50.7 81.9±31.7  < 0.0001
[min]
Blood loss [ml] 109.8±95.8 254.3±296.9  < 0.0001
Oral intake [h] 21.9±9.7 43.6±14.0  < 0.0001
Ambulation [h] 17.4±6.6 35.9±15.5  < 0.0001
Hospitalisation 4.6±2.2 6.8±3.6 < 0.0001
(days)
Return to normal- 13.7±7.4 22.8±10.7  < 0.0001
-activities (days)
Figure 1. A comparison of the ASA score in the LA and OA groups;
p = 0.0009, c2 test
Rycina 1. Porównanie wyników w skali ASA w grupach LA
i OA; p = 0,0009; test c2
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(range 12–48 h) versus 2 days after OA (range 24–72 h).
The mean time until full patient ambulation was shor-
ter than 1 day for the LA group (range 6–48 hours)
and was approximately 2 days for the OA group (range
12–72 h).
The average time of hospital stay for the LA group
(range 1–15 days) was 2 days shorter compared to the
OA group of patients (range 2–29 days). The mean time
until return to normal activity was half for the LA gro-
up (range 4–42 days) compared to the OA  group (ran-
ge 8–60 days).
The postoperative pain sensation, evaluated on the
first and the second day after surgery, was significantly
higher for the OA group (Fig. 2 and 3). During the first
day after surgery, narcotic analgesics (grade IV) were
given to 93.4% of patients in the OA group compared
to 24.2% of those who underwent LA. Intravenous in-
jections of ketoprofen (grade III) were given in 6.6% of
patients following OA whereas they were applied in
47.4% of LA patients. Grade 0–II was not observed in
any patient in OA but it was found in 28.4% of patients
following LA.
On the second postoperative day the pain sensation
was evaluated as grade III and IV in 44% and 29.3% of
patients, respectively, following OA compared to 14.7%
and 2.9%, respectively, following LA. Pain control wi-
thout intravenous analgesia (grade 0–II) was possible in
26.7% of patients following OA versus 82.3% after LA.
Intraoperative complications were observed in 12.9%
(n = 18) of patients undergoing LA versus 15.4% (n = 12)
in the OA group (p = 0.68). The specific types of com-
plications are shown in Table IV.
Postoperative complications occurred in 10.2% of LA
patients (n = 14) and in 15.5% following OA (n = 12)
(p = 0.28). The types of postoperative complications are
presented in Table IV.
There was one death in the LA group of patients
(0.7%) and one in the OA group of patients (1.3%).
Of the patients undergoing LA, 16.2% (n = 28) ne-
eded the conversion to OA. The conversion was done
because of difficulties in identifying or preparing the
adrenal tumour in 11 (6.3%) cases, due to bleeding from
the adrenal gland or the adrenal vein in 7 (4.0%) pa-
tients, due to injury of the peritoneum in 3 (1.7%) pa-
tients, and following injury of the spleen in 2 (1.2%)
cases. In the remaining 5 (0.6% for each case) patients,
the causes of the conversion were as followed: injury
of the pleura and pneumothorax, size of the adrenal
tumour exceeding 8 cm, identification of a malignant
adrenal tumour, bleeding from the inferior caval vein,
and lesion of the liver capsule.
There were no statistically significant differences
found regarding the ASA score, age of patients, the side
and size of the adrenal tumour, or the indication for
surgery between LA and the converted procedures.
A comparison of intraoperative and postoperative
outcomes of LA and OA with converted laparoscopic
procedure is presented in Table V. The data show that
except for the time of the ambulation and the return to
normal activity, the conversion from LA to open proce-
dure resulted in significantly different intraoperative
and postoperative outcomes compared to LA and OA.
Moreover, in most of the analyzed endpoints of the
converted laparoscopic procedure, significantly worse
outcomes were observed compared to those of OA.
The pain sensation was significantly higher on the
first day after OA compared to the LA and converted
laparoscopic procedures (3.9 v. 2.9 v. 3.5; pO-C = 0.013,
pL-C = 0.0008, respectively). On the second postoperati-
ve day it differed significantly only between the LA and
the converted procedure (1.4 v. 3.0, pL-C < 0.0001).
Postoperative complications were observed in 16.0%
(n = 4) of patients undergoing the conversion from LA
Figure 3. A comparison of pain sensation evaluated on the second
day after surgery using the five grade scale; p < 0.0001, c2 test
Rycina 3. Porównanie dolegliwości bólowych w drugiej dobie po
zabiegu w 5-stopniowej skali; p < 0,0001, test c2
Figure 2. A comparison of pain sensation evaluated on the first
day after surgery using the five grade scale; p < 0.0001, c2 test
Rycina 2. Porównanie dolegliwości bólowych w pierwszej dobie
po zabiegu w 5-stopniowej skali; p < 0,0001, test c2
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to OA, including wound infections in three patients and
haematoma of the retroperitoneal space in one case. The
incidence of the postoperative complications did not
differ significantly among LA, OA, and converted lapa-
roscopic adrenalectomy.
The most common postoperative histopathologi-
cal diagnosis was adenoma (Table VI). In three cases
the histopathological diagnosis was not available. The
specific histopathological diagnoses of benign adrenal
tumours were equally distributed in both groups. Two
adrenocortical carcinomas were operated on laparo-
scopically. One of these procedures was converted to
open adrenalectomy because of the presence of tumo-
ur infiltration of the surrounding tissues. In both ca-
ses the adrenal tumour was preoperatively diagnosed
as benign.
Table V. The intraoperative and postoperative outcome of LA, OA, and converted LA
Tabela V. Śródoperacyjne i pooperacyjne wyniki LA, OA i konwersji z LA do OA
Converted LA p value
Mean ± SD (n = 28) Converted LA  v. LA Converted  LA  v. OA
Duration of surgery [min] 150.8 ± 46.8  < 0.0001 < 0.0001
Blood loss [ml] 363.2 ± 318.7 0.0002 0.015
Oral intake [h] 37.7 ± 15.5  < 0.0001 0.041
Ambulation [h] 28.4 ± 15.5 0.0002 0.052
Hospitalisation (days) 8.8 ± 5.7  < 0.0001 0.021
Return to normal activities (days) 26.7 ± 12.4  < 0.0001 0.14
Table VI. Postoperative histopathological diagnosis of all
removed adrenal tumours
Tabela VI. Histopatologiczne rozpoznanie pooperacyjne
wszystkich usuniętych guzów nadnerczy
Histopathology n (%)
Adenoma 195 (65.7)
Pheochromocytoma 41 (13.8)
Hypertrophia 16 (5.4)
Myelolipoma 8 (2.7)
Cystis 6 (2.0)
Normal glandule suprarenalis 6 (2.0)
Carcinoma 13 (4.4)
Metastatic 3 (1.0)
Other 9 (3.0)
Total 297
Table IV. Intraoperative and postoperative complications of LA and OA
Table IV. Śródoperacyjne i pooperacyjne powikłania LA i OA
Laparoscopic (n = 139) n (%) Open (n = 78) n (%)
Intraoperative Minor complications 16 (11.5) Minor complications 7 (9.0)
Complications Moderate tissue bleeding 6 (4.3) Moderate tissue bleeding 6 (7.7)
Adrenal vein lesion 2 (1.4) Liver capsule injury 1 (1.3)
Small peritoneum injury 4 (2.9) Major complications 5 (6.4)
Liver capsule injury 3 (2.2) Caval vein lesion 2 (2.6)
Gallbladder lesion 1 (0.7) Left renal artery injury 1 (1.3)
Major complications 2 (1.4) Right iliac artery injury 1 (1.3)
Pleura injury (pneumothorax) 2 (1.4) Pancreas injury 1 (1.3)
Postoperative Minor complications 9 (6.6) Minor complications 9 (11.6)
Complications Wound infection 3 (2.2) Wound infection 4 (5.2)
Retroperitoneal haematoma 3 (2.2) Retroperitoneal haematoma 2 (2.6)
Neuralgia 3 (2.2) Neuralgia 1 (1.3)
Anaemia-single transfusion blood 2 (2.6)
Major complications 5 (3.6) Major complications 3 (3.9)
Acute adrenal failure 1 (0.7) Acute adrenal failure 1 (1.3)
Ischaemic cardiac disease 2 (1.4) Acute respiratory failure 1 (1.3)
Pneumothorax 1 (0.7) Pancreatic fistula 1 (1.3)
Peritoneal bleeding — laparotomy 1 (0.7)
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Discussion
Indications for adrenal surgery had been well establi-
shed before the introduction of minimal invasive tech-
niques. Functional adrenal tumours are still common
disorders requiring surgery. LA has recently been con-
sidered by many authors as a “gold standard” in the
removal of benign adrenal functioning tumours [6,
12–14]. Additionally, during the last two decades an in-
creasing number of incidentally discovered adrenal
non-functioning lesions accompanied by the availabili-
ty of LA has prompted a discussion regarding the opti-
mal indications for surgery in such tumours [7, 15]. The
increasing number of patients diagnosed with inciden-
talomas is a direct consequence of the common use of
ultrasound, CT, and MRI imaging of the abdominal ca-
vity for various indications. The main indication for re-
moval of a non-functioning benign adrenal tumour is
the lesion diameter. However, there is no consensus in
the literature regarding the optimal size of the tumour
in need of surgical intervention. In our institution, pre-
operative diagnosis of incidentaloma was the indica-
tion to surgery in 64% of patients submitted to LA ver-
sus 55% of patients undergoing OA. After ten years of
our own experience with LA, and based on the availa-
ble studies [6, 16, 17], we accept the diameter of inci-
dentalomas between 4 and 8 cm as an indication for
preferred laparoscopic approach. Solid, benign, and
non-functioning adrenal lesions with diameter of less
than 4 cm are considered for surgery only in patients
with severe blood hypertension after all the other po-
ssible causes of hypertension were excluded [18]. Ac-
cording to our surgical protocol, we perform OA if the
diameter of the adrenal lesion exceeds 8 cm. The limi-
ted retroperitoneal space and the technical ability of
laparoscopic procedure restrict the feasibility of a safe
laparoscopic dissection of lesions bigger than 8 cm [6].
Moreover, the incidence of malignancy is higher in ca-
ses of lesions of diameter greater than 6 cm [13, 19]. Sin-
ce minimal invasive surgery was introduced in our in-
stitution in 1995, OA has been used to remove only
51 benign adrenal tumours versus 171 done by LA. Most
of those 51 patients submitted to OA did not agree to
be operated on with a laparoscopic approach, and in
few cases they had severe contraindications for LA (e.g.
unilateral adrenal tumour in a patient after nephrecto-
my or size of the tumour greater than 8 cm).
The optimal choice of surgical approach in adrenal
surgery depends on many factors. The most important
includes the dimensions of the mass, its location, the
endocrine and oncological nature of the lesion, the pa-
tient preoperative condition, and the surgeon’s expe-
rience [13]. Small functioning or non-functioning adre-
nal adenomas and other benign adrenocortical tumo-
urs may be successfully removed by employing LA [16,
20, 21]. The retroperitoneal laparoscopic approach pro-
vides direct access to the adrenal gland avoiding pre-
paration of other abdominal organs [22–26]. However,
the limited volume of retroperitoneal space restricts the
feasibility of access to small adrenal masses. Neverthe-
less, it should be advocated in patients with a history of
previous abdominal surgery [27]. According to the pu-
blished data and our own experience, transperitoneal
laparoscopic adrenalectomy is particularly suitable for
pheochromocytoma and lesions ranging between 6 and
8 cm in diameter [21, 28–30]. Posterior retroperitoneal
access was also shown to be feasible when applied to
the removal of chromaffin tumours [31–33]. This appro-
ach enables the ligation of the adrenal vein in the early
stages of the procedure. Transperitoneal and retroperi-
toneal (lateral and posterior) open adrenal surgery has
the same advantages and disadvantages with regard to
access to the adrenal tumour as laparoscopic appro-
aches. However, a suspicion or definitive preoperative
diagnosis of invasive adrenal carcinoma or malignant
pheochromocytoma represents, in many centres, a spe-
cific indication for open transperitoneal surgery [20, 29,
34–36]. It gives wide operative access to the adrenal tu-
mour as well as allowing the detailed inspection of the
surrounding organs and their possible infiltration [37].
Nevertheless, some authors have proved that in care-
fully selected cases metastatic adrenal lesions or adre-
nal carcinomas that do not infiltrate surrounding tissue
may be treated laparoscopically [12, 13, 29, 34, 35,
38–46). However, in view of our limited experience in
laparoscopic removal of malignant adrenal tumours,
this indication appears very controversial. We needed
to convert LA to OA in one case of malignant lesion
due to bleeding from the tumour and its infiltration into
the surrounding organs, which was not detected pre-
operatively.
Laparoscopic adrenalectomy requires a longer ope-
rative time compared to OA [6, 8, 13]. It seems to be
a major disadvantage of minimal invasive surgery. Our
study has also revealed the significantly longer mean
duration of laparoscopic versus open adrenalectomy.
However, the analysis of our results showed that the
time of surgery depends mainly on the experience of
the surgeon (or surgical team), expressed as a “learning
curve”. After our first 30 procedures, the mean time of
LA stabilized at a level of approximately 130 minutes,
and the last 20 operations were carried out within an
average time of 90 minutes. It has been suggested that
the “learning curve” reaches a plateau after 25 to
100 LA [33, 34, 47, 48]. In our opinion, the main reason
for the longer duration of adrenalectomy, besides the
“learning curve”, is the difficulty in identifying adrenal
tumours during retroperitoneal laparoscopic procedure.
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On other hand, the introduction of new and modern
laparoscopic equipment (e.g. ultrasonic scissors, lapa-
roscopic ultrasound probes, etc.) in the last two deca-
des had a clear influence on the decrease of the dura-
tion and blood loss in minimal invasive surgery [34].
Many authors reported reduced blood loss in the
case of LA compared to OA [8, 9, 10, 48]. In our analysis,
intraoperative bleeding was significantly lower for LA
versus OA. We believe that this results from the better
visualisation of the adrenal gland achieved by the lapa-
roscopic magnification of the operative field. Moreover,
the short distance between laparoscopic optic and ad-
renal gland, as well as precise dissection, allows a de-
crease of the blood loss during LA [49]. In our study we
also observed the influence of the “learning curve” on
the decrease of intraoperative blood loss in LA. The
mean blood loss decreased by almost a half after the
first 20 laparoscopic procedures. We have noticed a fur-
ther significant decrease in blood loss since the intro-
duction of harmonic scissors in 2001 in our institution.
The present study shows that LA is advantageous
compared to OA in terms of faster recovery, the ability
to resume oral diet quickly, short hospital stay, and shor-
ter time until full ambulation and a return to normal
activities. Similar outcomes were observed by other gro-
ups [6–8, 10]. These advantages of LA may reflect a si-
gnificant reduction of postoperative pain and limited
tissue trauma in the case of minimal invasive surgery
[8, 48]. Furthermore, LA limits the duration of the po-
stoperative ileus [48]. Shorter time until ambulation may
limit the incidence of postoperative complications such
as respiratory disorders or deep venous thrombosis.
Shorter hospital stay and quicker return to normal acti-
vities may further reduce the economic and social con-
sequences of adrenalectomy [3].
We observed a slightly lower incidence of intraope-
rative and postoperative complications after LA, com-
pared to OA, although the difference did not reach sta-
tistical significance. Most of the intraoperative and po-
stoperative complications of LA and OA were minor
ones. The major intraoperative complications were only
found in 1.4 and 6.4% of cases of LA and OA, respecti-
vely. In two cases of pleura injury observed within the
LA, we drained the pleural cavity and accomplished the
laparoscopic procedure without the conversion. Serio-
us complications of OA, such as left renal artery and
right iliac artery injury as well as the lesion of the pan-
creas, did not occur in our centre within the last fifteen
years, suggesting the possible influence of the “learning
curve”. Serious postoperative complications were found
in 3.6 and 3.9% in cases of LA and OA, respectively.
Pneumotorax, peritoneal bleeding, and pancreatic fistu-
la resulted directly from the surgical procedure while
the other serious postoperative complications were
mainly related to the nature of the adrenal tumour and
the patient’s general condition prior to surgery.
Pneumothorax was the cause of death of the patient
undergoing the converted LA. The patient died on the
second postoperative day due to respiratory and circu-
latory failure. The mortality in the OA group occurred
in the third postoperative week due to intraoperative
injury of the pancreas leading to pancreatic fistulae and
sepsis.
The overall rate of conversion from LA to OA in our
study was 16%, while it ranges from 3 to 10% in other
reports [50–54]. The most frequent reason for conver-
sion to OA was the technical difficulty in identifying or
dissecting the adrenal tumour. This technical problem
could be associated with the small retroperitoneal spa-
ce and the lack of clear anatomical topography of it [25].
Performance of retroperitoneal laparoscopic adrenalec-
tomy was particularly difficult for surgeons who did
not have previous experience in other retroperitoneal
laparoscopic procedures. Bleeding from the adrenal
gland, its surroundings, or adrenal vein could be also
difficult to control laparoscopically in the case of retro-
peritoneal access, mainly because of the lack of retro-
peritoneal space. This was a common cause of conver-
sion in our series. Injury of the peritoneum during re-
troperitoneal laparoscopic adrenalectomy resulted in
a further decrease of the already small retroperitoneal
space making it impossible to continue the laparosco-
pic procedure in many cases. On the other hand, injury
of the spleen as well as the liver capsule resulted in co-
nversion in cases of transperitoneal adrenalectomy. This
was due to the need of dissection of the spleen or the
liver during the left or the right transperitoneal laparo-
scopic adrenalectomy. The other complications respon-
sible for conversion were very rare, achieving a rate of
less than 3% of all laparoscopic procedures.
As opposed to some other groups, we did not observe
any statistically significant influence of the side or size of
the adrenal tumour on the conversion rate [52, 53].
Conversion from LA to OA has a significant influ-
ence on the intraoperative and postoperative outcome
of the adrenalectomy. It is particularly important in the
outcome assessment of the primary OA and the conver-
sion. The conversion may be associated with inferior
intraoperative and postoperative results as compared
to the primary open adrenalectomy. However, the rate
of complications of LA, OA, and the converted laparo-
scopic adrenalectomies was similar. Moreover, there
were no serious postoperative complications following
the conversion.
Adenoma of the adrenal gland was the most com-
mon histopathological diagnosis among the removed
adrenal tumours in our centre. It corresponds with the
data published by other authors [6, 7, 15, 16]. The rate
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of the histopathological nature of adrenal tumours re-
moved by LA or OA did not differ significantly in our
series. However, as already mentioned, the malignant
adrenal lesions were planned to be removed in our de-
partment by open surgery.
Conclusions
This study shows that LA is a safe, effective, and well-
tolerated procedure. We recommend laparoscopic ad-
renalectomy as a “gold standard” in the surgery of both
functioning and non-functioning benign adrenal tumo-
urs of diameter less than 8 cm.
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